fosinopril has been researched along with Chronic Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Ma, Q; Ning, Y; Sun, M; Wu, S; Yang, L; Yang, T | 1 |
| Tereshchenko, SN; Zhirov, IV | 1 |
| Buyukhatipoglu, H; Tiryaki, O; Usalan, C | 1 |
| Berthier, C; Ferrari, P; Frey, FJ; Kappeler, A; Lods, N; Marti, HP; Vogt, B | 1 |
| Chen, X; Hong, Q; Shi, S; Wang, J; Wei, R; Yamanaka, N; Zhang, W | 1 |
| Blumenthal, M; Brown, EJ; Chew, PH; Gelperin, K; Ilgenfritz, JP; MacLean, A | 1 |
| Drozdov, VN; Ivleva, AIa; Kobalava, ZhD; Kotovskaia, IuV; Moiseev, VS; Moryleva, ON | 1 |
| Chati, Z; Guest, M; Plat, F; Zannad, F | 1 |
| Fang, TC; Huang, WC | 1 |
| Beck, L; Blanc-Guillemaud, V; Cherif, OK; Davy, JM; Jover, B | 1 |
1 review(s) available for fosinopril and Chronic Disease
| Article | Year |
|---|---|
[Fosinopril in the treatment of cardiorenal syndrome in chronic cardiac failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Fosinopril; Heart Failure; Humans; Renal Insufficiency; Sympathetic Nervous System; Syndrome; Treatment Outcome | 2009 |
6 trial(s) available for fosinopril and Chronic Disease
| Article | Year |
|---|---|
[Plasma tissue factor and serum angiotensin II and the therapeutic effect of different dosages of fosinopril on chronic heart failure].
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Thromboplastin | 2009 |
Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Chronic Disease; Diet, Sodium-Restricted; Down-Regulation; Drug Therapy, Combination; Female; Fibrinolysis; Fosinopril; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Renin; Spironolactone; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2010 |
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Case-Control Studies; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Fosinopril; Glomerulonephritis; Humans; Irbesartan; Male; Matrix Metalloproteinases; Middle Aged; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Tetrazoles | 2003 |
Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group.
Topics: Aged; Chronic Disease; Diuretics; Double-Blind Method; Exercise Test; Female; Fosinopril; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Prospective Studies | 1995 |
[Fosinorm in the treatment of essential hypertension with a metabolic syndrome].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Syndrome; Time Factors | 1997 |
Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Fosinopril; France; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome | 1998 |
4 other study(ies) available for fosinopril and Chronic Disease
| Article | Year |
|---|---|
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antigen-Antibody Complex; Blood Pressure; Chronic Disease; DNA; DNA-Binding Proteins; Female; Fosinopril; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; Kidney; Phosphorylation; Proteinuria; Rats; Rats, Wistar; STAT3 Transcription Factor; Tissue Inhibitor of Metalloproteinase-1; Trans-Activators | 2005 |
Role of angiotensin II in hyperinsulinemia-induced hypertension in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Fosinopril; Hyperinsulinism; Hypertension; Insulin; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley | 1998 |
Effects of spironolactone and fosinopril on the spontaneous and chronic ventricular arrhythmias in a rat model of myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Chronic Disease; Disease Models, Animal; Electrocardiography, Ambulatory; Fosinopril; Heart Rate; Heart Ventricles; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Random Allocation; Rats; Rats, Wistar; Spironolactone; Time Factors; Ventricular Dysfunction; Ventricular Premature Complexes | 2001 |